| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/04/2001 | CA2377200A1 Pyrazolidinol compounds |
| 01/04/2001 | CA2377186A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
| 01/04/2001 | CA2376935A1 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 01/04/2001 | CA2365341A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/04/2001 | CA2341974A1 Gonadotropin releasing hormone antagonist |
| 01/03/2001 | EP1064375A2 Human calcium-binding proteins |
| 01/03/2001 | EP1064370A2 Protein phosphatase-related molecules |
| 01/03/2001 | EP1064362A1 Nek1-related protein kinase |
| 01/03/2001 | EP1064355A2 Development of normal offspring from oocytes injected with freeze-dried spermatozoa |
| 01/03/2001 | EP1064284A1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
| 01/03/2001 | EP1064262A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 01/03/2001 | EP1064012A1 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding |
| 01/03/2001 | EP1064009A1 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 01/03/2001 | EP1063999A1 Epiallopregnanolone in the treatment of cns disorders |
| 01/03/2001 | EP1063996A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v 1a? and v 2? receptors |
| 01/03/2001 | EP1063990A1 Therapy of estrogen-associated disorders |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | CN1278822A 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/03/2001 | CN1278812A 2-aryl-3-aroylbenzo [b] thiophenes for treatment of estrin deficiency |
| 01/03/2001 | CN1278811A 2-Arylbenzo[b] thiophenes useful for the treatment of estrogen deprivtion syndrome |
| 01/03/2001 | CN1278810A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278809A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278735A Vaginal suppository vaccine for urogenital infections |
| 01/03/2001 | CN1278732A Anti-estrogen plus progestin containing oral contraceptives |
| 01/03/2001 | CN1278724A Indeno [1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activty |
| 01/03/2001 | CN1278435A Collyrium for treating gynopathy and its production process |
| 01/03/2001 | CN1278429A Controlled-releasing vaginal tinidazole collyrium and its preparation |
| 01/03/2001 | CN1060178C Derivatives of structurally modified vip and pharmacetical compositions containing them for treating servual impotense of male |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060073C Externally used medicine bag for curing chroic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process |
| 01/03/2001 | CN1060049C Chinese medicine ganshenxianbao for curing liver and kidney diseases and its preparing method |
| 01/03/2001 | CN1060039C Inhibition of smooth muscle cell migration by (R)-amlodipine |
| 01/02/2001 | US6169105 Potentiating the action of paroxetine in increasing the availability of serotonin, norepinephrine and dopamine in the brain by administering paroxetine to a patient in need thereof in combination with way 100635 |
| 01/02/2001 | US6169082 Salts of 8,9-dehydroestrone sulfate ester |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 01/02/2001 | CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078933A2 Novel calpains and their use |
| 12/28/2000 | WO2000078802A2 Secreted polypeptides and corresponding polynucleotides |
| 12/28/2000 | WO2000078768A1 Potassium channel openers |
| 12/28/2000 | WO2000078767A1 Thienopyrimidines as phosphodiesterase inhibitors |
| 12/28/2000 | WO2000078753A1 Process for the preparation of paroxetine and structurally related compounds |
| 12/28/2000 | WO2000078697A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | WO2000078339A1 Uterine contraction inhibitors |
| 12/28/2000 | WO2000078335A1 COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS |
| 12/28/2000 | WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/28/2000 | WO2000078328A2 USE OF GROWTH HORMONE (hGH) FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISTURBANCES |
| 12/28/2000 | WO2000078323A1 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases |
| 12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | WO2000078319A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | WO2000078313A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 12/28/2000 | WO2000056353A3 A uro-genital condition treatment system |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000035465A3 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 12/28/2000 | CA2377698A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | CA2377339A1 Administration of growth hormone (hgh) for the therapy of sexual functional disorders |
| 12/28/2000 | CA2377263A1 Polynucleotides and polypeptides encoded thereby |
| 12/28/2000 | CA2377246A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375477A1 Novel calpains and their use |
| 12/28/2000 | CA2375396A1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | CA2375282A1 Potassium channel openers |
| 12/28/2000 | CA2375278A1 Thienopyrimidines |
| 12/28/2000 | CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/27/2000 | EP1063293A2 Transforming growth factor alpha H1 |
| 12/27/2000 | EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1062215A1 Antagonists of gonadotropin releasing hormone |
| 12/27/2000 | EP1061928A2 New contraceptive kit |
| 12/27/2000 | CN1277871A Traditional Chinese medicine prepn. for treating puerperal fever and gynaopathy uterine bleeding |
| 12/27/2000 | CN1059834C Pure traditional Chinese medicinal liquor with antisenile action |
| 12/26/2000 | US6166219 Treatment of diabetes and related disorders |
| 12/26/2000 | US6166061 Methods and formulations for modulating the human sexual response |
| 12/26/2000 | US6166040 Treating a disorder of the central nervous system |
| 12/26/2000 | US6166034 Spiro piperidine derivatives as 5HT1D receptor antagonists |
| 12/26/2000 | US6166005 Heterocyclic metalloprotease inhibitors |
| 12/26/2000 | US6165975 Microdose therapy |
| 12/26/2000 | US6165767 Protein phosphatase-related molecules |
| 12/26/2000 | US6165751 HLDAT86 polynucleotides |
| 12/26/2000 | US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist |
| 12/26/2000 | US6165492 Intrauterine chemical necrosing method, composition, and apparatus |
| 12/21/2000 | WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 12/21/2000 | WO2000077040A2 Human intracellular signaling molecules |
| 12/21/2000 | WO2000077023A1 48 human secreted proteins |
| 12/21/2000 | WO2000077018A2 Purine derivatives |
| 12/21/2000 | WO2000077010A2 Substituted heterocycle fused gamma-carbolines |
| 12/21/2000 | WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 12/21/2000 | WO2000077002A1 Substituted heterocycle fused gamma-carbolines |
| 12/21/2000 | WO2000077001A1 Substituted heterocycle fused gamma-carbolines |
| 12/21/2000 | WO2000076984A2 Novel compounds, their use and preparation |
| 12/21/2000 | WO2000076531A1 47 human secreted proteins |
| 12/21/2000 | WO2000076522A1 Administration of non-oral androgenic steroids to women |
| 12/21/2000 | WO2000076509A1 Nasal delivery of apomorphine |
| 12/21/2000 | WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 12/21/2000 | WO2000066736B1 Growth factor homolog zvegf4 |
| 12/21/2000 | WO2000053628A3 Genes encoding human potassium channel proteins |
| 12/21/2000 | WO2000047580A3 Phenyl urea and phenyl thiourea derivatives |
| 12/21/2000 | WO2000045791A3 Method for controlling liposome size |